The world's latest technology in cervical screening. Learn more
Truscreen Limited advises that it has issued new shares and unlisted share options as follows
NZX Announcement Please see attached an ongoing disclosure notice in relation to Anthony Ho, Chairman.
TruScreen’s cervical cancer screening device demonstrates improved sensitivity and specificity targeting pre-cancerous and cancerous cervical cells
The Annual Meeting of Shareholders of Truscreen Limited (NZX:TRU) was held today 27 August 2019. All resolutions were passed by a poll of shareholders present…
TruScreen Annual Meeting Presentation by Chief Executive Officer
TruScreen Limited, advises that its Annual Meeting will be held at Link Market Services, Level 11, Deloitte Centre, 80 Queen St, Auckland, on Tuesday 27…
Dr. Carolina Velasquez traveled to Vietnam to conduct clinical training and launch the TruScreen Pilot Study, being conducted out of Hanoi Gynaecology and Obstetrics Hospital.…
TruScreen is pleased to provide a copy of its July 2019 Stakeholders Newsletter, providing an update on TruScreen’s performance and highlights key initiatives underway.